Viewing Study NCT05263869


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-05-27 @ 1:50 PM
Study NCT ID: NCT05263869
Status: UNKNOWN
Last Update Posted: 2022-12-02
First Post: 2022-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients
Sponsor: Shanghai Miracogen Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer With Liver Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MRG002 View
None Antibody Drug Conjugate (ADC) View
None HER2 View